Related Experiment Video
Updated: Sep 4, 2025

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
Published on: March 10, 2023
Eponyms in Malignant Hematology.
Danielle Brazel1, Priyanka Kumar1, David J Benjamin2
1Department of Medicine, University of California, Irvine Medical Center, Orange, California, United States.
This review examines medical eponyms in malignant hematology, detailing disease pathophysiology, epidemiology, and the history of honorees. It addresses ethical concerns surrounding these disease names.
Area of Science:
- Medical Humanities
- Hematology
- Medical Ethics
Background:
- Medical eponyms traditionally honor individuals for disease discoveries.
- Concerns arise regarding the backgrounds of individuals honored by eponyms.
- Previous work reviewed oncology eponyms; this study focuses on hematology.
Purpose of the Study:
- To review commonly used eponyms in malignant hematology.
- To highlight the individuals after whom these hematologic conditions are named.
- To discuss the historical context of eponyms in hematology.
Main Methods:
- Literature review of malignant hematology eponyms.
- Analysis of disease pathophysiology and epidemiology.
- Historical research into the individuals honored by eponyms.
Main Results:
- Identified and analyzed key eponyms in malignant hematology.
- Detailed the scientific contributions and historical backgrounds of associated individuals.
- Provided context on the ongoing debate surrounding medical eponyms.
Conclusions:
- Understanding the history behind malignant hematology eponyms is crucial.
- This review facilitates informed discussion on the use of eponyms in medicine.
- Acknowledges the ethical considerations in medical nomenclature.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Erythropoiesis
Differentiation of Common Myeloid Progenitor Cells
Targeted Cancer Therapies
There are several types of targeted therapies against...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Hematopoiesis

